["--- Page 1 ---\nREVIEW\npublished:16July2018\ndoi:10.3389/fbioe.2018.00099\nBlood-Contacting Biomaterials: In\nVitro Evaluation of the\nHemocompatibility\nMarbodWeber,HeidrunSteinle,SoniaGolombek,LudmillaHann,ChristianSchlensak,\nHansP.WendelandMeltemAvci-Adali*\nDepartmentofThoracicandCardiovascularSurgery,UniversityHospitalTübingen,Tübingen,Germany\nHemocompatibilityofblood-contactingbiomaterialsisoneofthemostimportantcriteria\nfor their successful in vivo applicability. Thus, extensive in vitro analyses according to\nISO 10993-4 are required prior to clinical applications", ". In this review, we summarize\nessentialaspectsregardingtheevaluationofthehemocompatibilityofbiomaterialsand\ntherequiredinvitroanalysesfordeterminingthebloodcompatibility.Static,agitated,or\nshearflowmodelsareusedtoperformhemocompatibilitystudies.Beforeandafterthe\nincubation of the test material with fresh human blood, hemolysis, cell counts, and the\nactivation of platelets, leukocytes, coagulation and complement system are analyzed.\nFurthermore,thesurfaceofbiomaterialsareevaluatedconcerningattachmentofblood\nEditedby:\ncells,adsorptionofproteins,andgenerationofthrombusandfibrinnetworks.", "Editedby:\ncells,adsorptionofproteins,andgenerationofthrombusandfibrinnetworks.\nNihalEnginVrana,\nProtipMedical,France\nKeywords:hemocompatibility,bloodcontact,biomaterials,coagulation,complementsystem\nReviewedby:\nGiovannVozzi,\nUniversitàdegliStudidiPisa,Italy INTRODUCTION\nElifVardar,\nCentreHospitalierUniversitaire\nHemocompatibility is one of the major criteria, which limit the clinical applicability of blood-\nVaudois(CHUV),Switzerland\ncontacting biomaterials", ". These materials come in close contact with blood, which is a complex\n*Correspondence: “organ,” comprising of 55% plasma, 44% erythrocytes, and 1% leukocytes and platelets", ". Thus,\nMeltemAvci-Adali\nadverseinteractionsbetweennewlydevelopedmaterialsandbloodshouldbeextensivelyanalyzed\nmeltem.avci-adali@uni-tuebingen.de\ntopreventactivationanddestructionofbloodcomponents.Theinitiallyadsorbedproteinlayeron\nthebiomaterialsurfacemainlytriggerstheadversereactions,suchastheactivationofcoagulation\nSpecialtysection:\nviaintrinsicpathway,theactivationofleukocytes,whichresultsininflammation,andtheadhesion\nThisarticlewassubmittedto\nBiomaterials, andactivationofplatelets(Liuetal.,2014).Asaresult,thenumberofbloodcellscandecreaseand\nasectionofthejournal athrombuscanbeformed.", "Biomaterials, andactivationofplatelets(Liuetal.,2014).Asaresult,thenumberofbloodcellscandecreaseand\nasectionofthejournal athrombuscanbeformed.\nFrontiersinBioengineeringand Thus,theappliedblood-contactingbiomaterialsshouldnotadverselyinteractwithanyblood\nBiotechnology components and activate or destruct blood components", ". Erythrocytes are the most abundant\nReceived:12May2018 bloodcellswith4–6×106 cells/µlandtheyareimportantforthetransportofoxygen(O 2 )from\nAccepted:26June2018 the lung to all tissues and cells and carbon dioxide (CO ) from tissues back to the lung. Since\n2\nPublished:16July2018 erythrocytes are the most rigid cells in the blood, they are sensitive to rupture and hemolysis\nCitation: due to shear stress and changes in osmotic pressure", ". Blood platelets are the smallest (1–3µm)\nWeberM,SteinleH,GolombekS, and the second abundant cell type in the blood with 1.5–3.5 × 105 cells/µl, which can rapidly\nHannL,SchlensakC,WendelHPand recognize foreign surfaces and initiate blood coagulation. Furthermore, human blood contains\nAvci-AdaliM(2018)Blood-Contacting 4.3–10×103 leukocytes/µl,suchasgranulocytes,lymphocytes,monocytes,dendriticandnatural\nBiomaterials:InVitroEvaluationofthe\nkillercells.Monocytesaccountfor1–6%ofallleukocytesandneutrophilgranulocytesarethemost\nHemocompatibility.\nFront.Bioeng.Biotechnol.6:99", ". abundantleukocytesintheblood,comprising50–70%ofallleukocytes.Theseimmunecellsare\ndoi:10.3389/fbioe.2018.00099 belonging to the innate immune system and they can be rapidly activated upon recognition of\nFrontiersinBioengineeringandBiotechnology|www.frontiersin.org 1 July2018|Volume6|Article99", "--- Page 2 ---\nWeberetal. HemocompatibilityofBlood-ContactingBiomaterials\na foreign invader such as a pathogen or a foreign material.\nFurthermore, blood plasma contains high amounts of\nplasma proteins, such as albumin, coagulation factors, and\nimmunoglobulins.\nCatheters,guidewires,dialyzer,oxygenators(artificiallungs),\nheart-supporting systems, cardiac pacemaker, vascular grafts,\nstents, heart valves, micro-, and nanoparticles are widely used\nmedical devices and materials coming in direct contact with\nblood", ". Prior to clinical application, the hemocompatibility\nof blood-contacting medical materials have to be analyzed\nand therefore, a guidance is developed by the International\nOrganization for Standardization (ISO 10993-4) (International\nOrganization for Standardization, 2000)", ". According this\nguideline, five different categories, thrombosis, coagulation,\nplatelets, hematology, and immunology (complement system\nandleukocytes),areindicatedforhemocompatibilityevaluation.\nThe devices are divided into three categories concerning blood\ncontact: (1) Externally communicating devices with indirect\nblood contact, e.g., cannulas and blood collection sets; (2)\nExternally communicating devices with direct blood contact,\ne.g.,cathetersandhemodialysisequipment;(3)Implantdevices,\ne.g.,heartvalves,stents,andvasculargrafts.Sofar,severalstudies", "e.g.,cathetersandhemodialysisequipment;(3)Implantdevices,\ne.g.,heartvalves,stents,andvasculargrafts.Sofar,severalstudies\nwere performed according ISO-10993-4 to evaluate various\nblood contacting devices and materials, such as stents (Sinn\netal.,2011;Stangetal.,2014),catheterswithanoblemetalalloy\ncoating (Vafa Homann et al., 2016), poly(2-dimethylamino- FIGURE1|Schematicrepresentationoftheprocedurefortheevaluationof\nethylmethacrylate) (PDMAEMA) (Cerda-Cristerna et al., thehemocompatibilityofbiomaterials.First,freshhumanbloodiscollected\n2011), and DNA hydrogels (Stoll et al., 2017)", ". To perform andanticoagulatedwithlowdoseheparin.Thereafter,thetestmaterialis\nincubatedat37◦Cusingstatic,agitated,ordynamictestmodelswiththe\nhemocompatibilityanalysis,static,agitated,orshearflowinvitro\nblood.Theactivationmarkersinthebloodareanalyzedbeforeandafterthe\nmodelsareusedfortheincubationofbloodwiththebiomaterial", ". incubationwiththetestmaterial.Furthermore,thesurfaceofthebiomaterialis\nBeforeandaftertheincubationofbiomaterialswithfreshhuman analyzedtodeterminetheinteractionofbloodcellsandproteinswiththe\nblood, the activation markers regarding hemocompatibility are biomaterialsurface.\nanalyzed(Figure1).\nshould be performed with fresh blood from healthy subjects\nINCUBATION OF BIOMATERIALS WITH (Blok et al., 2016). Blok et al", ". Blok et al. demonstrated that the stationary\nHUMAN BLOOD storageofbloodover4hatroomtemperatureaffectstheplatelet\nfunctionandactivityofleukocytes.Thus,experimentsshouldbe\nUsing fresh human blood and adequate in vitro models, the startedwithin4hafterthebloodcollection.However,thefaster\nhemocompatibility of blood-contacting biomaterials can be the experiments are started, the better it is", ". Peripheral blood\nstudiedaccurately.Comparedtoinvivoanimalmodels,invitro should be collected from healthy non-smoker, non-pregnant\nmodels allow the analysis under well controllable conditions subjects free of medication (particularly drugs affecting the\nsuch as blood flow, anticoagulation and eliminate disturbing hemostasis,suchasaspirin,oralcontraceptives,andnonsteroidal\nfactors related to flow obstruction, surgery, and tissue effects anti-inflammatorydrugs).Moreover,atraumaticbloodcollection\n(van Oeveren, 2013)", ". Furthermore, the blood contact is more byminimizingvenostasisduringbloodwithdrawalandtheuseof\nintense and products generated due to reaction of the blood 21-gaugeneedlesisrequired tominimizeactivationofplatelets\ncomponents to the biomaterial are not cleared. Moreover, and the coagulation cascade during collection (Braune et al.,\nusing in vitro models, different devices can be analyzed under 2013).\nthe same conditions, which enable the direct comparison Furthermore, prior to starting hemocompatibility analyses,\nof outcomes", ". Thereby, positive controls, which show a poor unreacted monomers, intermediate- or by-products, solvents,\nhemocompatibility, such as glass (Ferrer et al., 2013), devices and unwanted chemical residues should be removed by\nor biomaterials, which are already on the market with a appropriate washing and cleaning procedures from generated\ncomparable surface area, and negative controls without test biomaterials to eliminate an unwanted influence on blood\nmaterial should be simultaneously tested to be able to evaluate components.Dependingonbiomaterial,device,andproduction\nthehemocompatibility", ". technique, different washing and cleaning procedures with\nThequalityofcollectedbloodisextremelyimportanttoenable different solutions are required, for example ethanol can be\nstandardized hemocompatibility analysis. The in vitro analysis removed by evaporation or washing with PBS (Punet et al.,\nFrontiersinBioengineeringandBiotechnology|www.frontiersin.org 2 July2018|Volume6|Article99", "--- Page 3 ---\nWeberetal. HemocompatibilityofBlood-ContactingBiomaterials\n2015), NaCl, or water and unreacted methacrylic anhydride blood with air bubble to allow the blood mixture and rotated\n◦\nand by-products can be eliminated by dialysis (Xiao et al., in a water bath with 37 C to stimulate blood circulation", ". In\n2011;Camci-Unaletal.,2013).Additionally,endotoxincontent modified versions of the Chandler loop, small materials, such\nshouldbedeterminedtoexcludematerial-unrelatedactivationof as stents are inserted in tubings and then filled with blood\nplateletsandbloodcellsduetopresenceofendotoxins(Watanabe (Müller et al., 2012). Since the Chandler loop is partially filled\net al., 2003; Kälsch et al., 2007; Schrottmaier et al., 2016)", ". Since the Chandler loop is partially filled\net al., 2003; Kälsch et al., 2007; Schrottmaier et al., 2016). with air, the device circulates through an air-liquid interface.\nFurthermore,aprocesscalleddepyrogenationcanbeappliedto Thus, this method can lead to the denaturation of proteins at\nremove endotoxins from biomaterials (Li and Boraschi, 2016). the air-liquid interface (Thorsen et al., 1993;Ritz-Timme et al.,\nFor example by using detergents (e.g., Triton X-114) and a 1997) and the detachment of adhered blood cells", ". Therefore,\ntwo-phase extraction method, endotoxins can be eliminated roller pump closed-loop test systems were also used instead\n(Zhang et al., 2015). After the addition of the detergent to the of Chandler loop. Hereby, the blood flow is realized by using\nsample,endotoxinsareincorporatedintomicellesvianon-polar a pump", ". However, due to use of a pump even with lowest\ninteractionsofthesurfactantendgroupsandalkylchainsoflipid pumping rates a slight destruction of erythrocytes (hemolysis)\nA, which is the most conserved part of endotoxins (Magalhães canoccur.VanOeverenandcolleaguesanalyzedadditionallyto\netal.,2007).Theincreaseoftemperatureleadstotheformationof theChandlerloopandrollerpumpmodel,theHemobilemodel\nawaterphase(micelle-poor)andamicelle-richphase.Thereby, (Van Oeveren et al., 2012) regarding intrinsic damage of blood", "awaterphase(micelle-poor)andamicelle-richphase.Thereby, (Van Oeveren et al., 2012) regarding intrinsic damage of blood\nendotoxins remained in the micelle-rich phase (bottom-phase) components and activation of platelets", ". Hemobile model has a\ncanberemoved. one-wayballvalvetoensureunidirectionalflowandthetubing\ncontainsnoair,andthereisnomechanicaldevicecompressing\nStatic Blood Incubation Models the tubing. Thus, using this model, less blood trauma\nIn static blood incubation models, test materials are incubated was induced compared to Chandler-Loop and roller pump\nwithbloodorplatelet-richplasma(PRP)withoutflowconditions model.\n(Mohan et al., 2013)", ". Therefore, container, such as well However, the main limitation of these in vitro models is\nplates or tubes, can be used to incubate the material with a the lack of an endothelium in the circulating system. The\ncertain blood or PRP volume. It is a very simple and rapid endothelium produces cytokines, anti-thrombotic components\nmethod to determine the hemocompatibility of biomaterials, andexpressesadhesionmoleculesforthrombocytes,monocytes,\nespecially the thrombogenicity", ". However, this method provides and neutrophils and plays an important role in interaction\nonlyrudimentaryresultsregardinghemocompatibility.Thereby, betweenthecirculatingbloodandinjuredvesselwall.Therefore,\nmajorlimitationscanbethecellsedimentationandthebigblood- inarecentstudy,Nordlingetal.usedanovelbloodendothelial\nairinterface,whichcanleadtoaproteinaggregationandresult cell chamber model to study the interactions between human\ninplateletactivation(HaycoxandRatner,1993). whole blood and endothelium (Nordling et al., 2014)", ". There,\nthe blood contacting surface of incubation chambers were\nAgitated Blood Incubation Models seededwithhumanumbilicalveinendothelialcells(HUVECs).\nIn agitated blood incubation models, flat incubation chambers Furthermore,arelativelynewfieldfortheexaminationofplatelet\nwith top and bottom surfaces made of the test material are andcoagulationactivationistheuseofmicrofluidics(Kentetal.,\ncompletely filled with blood and incubated on a shaker or 2010;Onasoga-Jarvisetal.,2013,2014;Kovachetal.,2014;Zhu\noverhead rotator without directed flow (Streller et al., 2003)", ". et al., 2015; Nagy et al., 2017). Using microfluidic flow devices\nFurthermore,thecontainerfilledwiththebloodcanberotated plateletandcoagulationactivationcanbedeterminedatthesame\nto prevent the sedimentation of the test material, such as timeandunderdefined,physiologicalorpathological(stenotic)\nnanoparticles(Maitzetal.,2017).Usingthesemodels,theblood- wall shear rates. Due to the small size of microfluidic devices,\naircontactisalmostexcludedandcellsedimentationisreduced. only small amounts of blood are required", ". Furthermore, the\ncombinationwithfluorescencemicroscopyallowsthereal-time\nShear Flow Models opticalimagingofplateletadhesionandformationoffibrinfibers\nFlat-plate flow chambers (Van Kruchten et al., 2012), parallel- (Westeinetal.,2012;Zhuetal.,2015).\nplate and cone-platelet viscometer (Lackner et al., 2012), and\ntubular systems such as the “Chandler loop” (McClung et al.,\n2007; Krajewski et al., 2013; Stang et al., 2014) and the roller ANALYSIS OF HEMOCOMPATIBILITY\npumpclosed-loop(Podiasetal.,1995;Wangetal.,2001)systems", "pumpclosed-loop(Podiasetal.,1995;Wangetal.,2001)systems\naresomeofinvitroshearflowmodels.Inthesemodels,vascular Using the described in vitro models, various information\nblood flow is mimicked to simulate the dynamic interaction regarding hemocompatibility (Figure2) can be obtained: (1)\nbetweenthebiomaterialandwholeblood(SanakandWegrzyn, Changesofplatelets,erythrocytesandleukocytes,(2)Generation\n2010).In flat-plateflow chambers,blood flows over a flatpiece of activation products in plasma, (3) Deposition of proteins", "2010).In flat-plateflow chambers,blood flows over a flatpiece of activation products in plasma, (3) Deposition of proteins\nof biomaterial and in parallel-plate viscometers, blood is filled and cells on the material surface", ". Thus, blood and surface of\nbetweentwoplatesmadeofthebiomaterialtobetestedandone biomaterials are analyzed before and after the incubation. In\noftheplatesisrotatedrelativetotheother(Sukavaneshvar,2017). Table1, test categories for the hemocompatibility analysis of\nIn Chandler loop, a circular conduit made of the biomaterial biomaterialsaresummarizedandinthefollowing,therequired\nor coated with the biomaterial, is filled with fresh human analysesfortheevaluationofhemocompatibilityaredescribed.\nFrontiersinBioengineeringandBiotechnology|www.frontiersin.org 3 July2018|Volume6|Article99", "--- Page 4 ---\nWeberetal", ". HemocompatibilityofBlood-ContactingBiomaterials\nFIGURE2|Schematicrepresentationofmajorreactionsinbloodinducedbybiomaterialsurface.Besidescomplementsystem,intrinsicandextrinsiccoagulation\npathwaycanbeactivated.Coagulationactivationresultsingenerationofafibrinnetwork.Furthermore,plateletscanadhereandaggregateonthesurface.The\nadhesionandactivationofleukocytescanleadtothereleaseofpolymorphonuclear(PMN)elastaseandtissuefactor(TF)andresultinactivationofextrinsicpathway.", "adhesionandactivationofleukocytescanleadtothereleaseofpolymorphonuclear(PMN)elastaseandtissuefactor(TF)andresultinactivationofextrinsicpathway.\nADP,Adenosinediphosphate;β-TG,β-Thromboglobulin;GPIIb/IIIa,GlycoproteinIIb/IIIa;MAC,Membraneattackcomplex;PF4,Plateletfactor4;TXA2,Thromboxane\nA2;vWF,vonWillebrandfactor.\nDETERMINATION OF BLOOD CELL hemoglobin to the cyanoderivate (Neun and Dobrovolskaia,\nNUMBERS AND HEMOLYSIS 2011)", ". The absorption of CMH is measured at 540nm using a\nphotometer.Dependingonhemolysis,materialscanbeclassified\nThe number of erythrocytes, leukocytes, and platelets is in three different categories: Materials resulting in over 5%\nmeasured before and after the incubation of blood with hemolysisareclassifiedhemolytic,between5and2%asslightly\nbiomaterial using a hematology analyzer, which uses electrical hemolytic,andbelow2%asnonhemolytic(Toteaetal.,2014).\nimpedance", ". A decrease of the platelet count over time\nindicatesathrombogenicmaterial.Furthermore,theruptureof\nCOAGULATION ACTIVATION\nerythrocytes, called hemolysis, is accompanied by the release\nof hemoglobin", ". Thus, an increased concentration of free\nTheinteractionofplasmaproteinswithartificialsurfacestriggers\nhemoglobin in the plasma is a direct indicator of erythrocytes\nintrinsiccoagulationpathwaybycontactactivation.Thecontact-\ndestruction.Thedamageoferythrocytescanleadtothereduced\nphase system consists of three serine proteinases, factor XII,\noxygen transport to tissues and organs in vivo and increased\nfactorXI,andplasmaprekallikrein(PK),andthenonenzymatic\nlevelsoffreehemoglobincaninducetoxicityoralterthekidney\ncofactor high molecular weight kininogen (HMWK) and it is", "levelsoffreehemoglobincaninducetoxicityoralterthekidney\ncofactor high molecular weight kininogen (HMWK) and it is\nfunction(Qianetal.,2010).Additionally,microvesiclesderived\nalso called as plasma kallikrein-kinin system (Wu, 2015)", ". The\nfrom erythrocytes can promote the thrombus formation in a\ncontact of blood with artificial, negatively charged surfaces,\ntissue factor (TF)-dependent manner (Biró et al., 2003). Thus,\nsuch as kaolin, glass, collagen, silica, or dextran sulfate, leads\nhemolysiscanbeanalyzedafterdirectorindirectbloodcontact.\nto the conversion of Factor XII to the active enzyme Factor\nIn direct analysis, blood is incubated with the biomaterial and\nXIIa.FactorXIIaconvertsPKintoactivekallikreinandHMWK\nin indirect testing blood is incubated with biomaterial extract\ninto bradykinin", ". Besides coagulation, kallikrein and bradykinin\n(Kuhbier et al., 2017). Hemolysis can be detected by using\npromoteinflammation(Longetal.,2016).Kallikreincandirectly\na photometric colorimetric test (cyanmethemoglobin method)\nactivateneutrophils(Wachtfogeletal.,1995)andbradykinincan\n(Stadie, 1920). Thereby, the free amount of hemoglobin in stimulatethereleaseofnitricoxide(Baeetal.,2003),TNFα,and\nplasma is examined after the addition of cyanmethemoglobin\nIL-1 (Tiffany and Burch, 1989)", ". Factor XIIa activates Factor XI\n(CMH) reagent, e.g., Drabkin’s reagent, which rapidly converts\ntoXIaandinthefollowingstep,FactorIXisconvertedbyFactor\nFrontiersinBioengineeringandBiotechnology|www.frontiersin.org 4 July2018|Volume6|Article99", "--- Page 5 ---\nWeberetal. HemocompatibilityofBlood-ContactingBiomaterials\nTABLE1|Summaryoftestcategoriesforthehemocompatibilityanalysisof recorded to obtain the activated PTT (aPTT). A shortened\nbiomaterials. clottingtimeindicatesanactivationoftheintrinsicandcommon\npathways of coagulation by the test material", ". Untreated plasma\nTest Parameter Testprinciple\ncategory isusedasnegativecontrolandlatexorblackrubberaspositive\ncontrol.\nComplement C3a,C5a,Bb,C4d, ELISA\nSystem C5b-9\nACTIVATION OF COMPLEMENT SYSTEM\nCoagulation FactorXIIa,TAT,F1+ ELISA,Opticaldensity,\n2,freeactivethrombin, Viscoelasticity\nComplement system consists of more than 30 proteins\nFPA,aPTT\ncirculating in the blood and present as membrane-associated\nFibrinolysis D-Dimers Immunoturbidimetry,\nLPIA,ELISA proteins (Dunkelberger and Song, 2010)", ". In response to the\nPlatelets β-TG,PF4,numberof ELISA,CellCounter, recognition of foreign surface structures, complement factors\nplatelets, are sequentially activated in an enzyme cascade via three\nP-selectin,activated FACS different pathways: classical, alternative, and mannose binding\nGPIIb/IIIa\nlectin (MBL) pathway", ". All of these pathways lead to the\nHemolysis Numberof CellCounter generation of a C3 convertase, which cleaves C3 into a large\nerythrocytes,\nfragment C3b, which acts as an opsonin and a small fragment\nHemoglobin ColorimetricAssay\nC3a, which is an anapylatoxin that promotes inflammation.\nLeukocyte PMNelastase,ROS ELISA,fluorimetricor\nActivation detection,CD11b spectrophotometric Afterwards, C5 convertase is generated, which cleaves C5 in\nexpression methods,FACS C5a, which is an anapylatoxin, and C5b that binds to the", "expression methods,FACS C5a, which is an anapylatoxin, and C5b that binds to the\nSurface Plateletadhesion, SEM,Fluorescence foreign surface and initiates the generation of terminal lysis\nAnalysis aggregation,leukocyte microscopy complex (C5b-9, TCC), which is also called membrane attack\nadhesion complex (MAC)", ". As a result, microorganisms are eliminated\nPlasmaprotein ELISA,WesternBlot\nby lysis, opsonization and triggering a series of inflammatory\nadsorption\nreactions.\naPTT,activatedpartialthromboplastintime;β-TG,β-Thromboglobulin;C3a,Complement The contact of the artificial surface with blood leads to\nfactor3a;C5a,Complementfactor5a;C4d,Complementfactor4d;Bb,complement\nan immediate adsorption of serum proteins, e.g., fibrinogen,\nfactorBb;ELISA,Enzyme-linkedImmunosorbentAssay;FACS,Fluorescence-activated", "an immediate adsorption of serum proteins, e.g., fibrinogen,\nfactorBb;ELISA,Enzyme-linkedImmunosorbentAssay;FACS,Fluorescence-activated\ncell sorting; FPA, fibrinopeptide A; F1+2, Prothrombin fragment 1+2; LPIA, Latex albumin, and immunoglobulin G (IgG), to the surface of the\nphotometricimmunoassay;PF4,Plateletfactor4;TAT,thrombin-antithrombinIIIcomplex; material (Wetterö et al., 2000) and it results in a kinetic\nPMN elastase, Polymorphonuclear elastase; ROS, Reactive oxygen species; SEM, competitionbetweentheproteinsonthematerialsurface,which\nScanningelectronmicroscopy.", "Scanningelectronmicroscopy.\nis called the Vroman effect (Vroman et al., 1980)", ". During the\nfirst minutes, abundant proteins, such as fibrinogen, adsorb\nXIatoIXa,whichthenactivatesfactorX.Theconversionoffactor and they are progressively displaced by less abundant proteins\nX into factor Xa is the first common step in the coagulation with a higher affinity for the surface, such as HMWK, Factor\ncascade between the intrinsic and extrinsic pathways (Millar XII, and plasminogen (Ballet et al., 2010). Especially, the\net al., 2016)", ". Especially, the\net al., 2016). In addition, the activation of complement system complementproteinC3andIgGcanreadilybindtohydrophobic\ncanleadtothegenerationofTFbymonocytes,whichcanresult surfaces and lead to the activation of complement system.\nin activation of extrinsic pathway (Kappelmayer et al., 1993). Thereby, the following conformational changes on the blood-\nFactorXaconvertsprothrombintothrombin,whichhydrolyses contacting surface are considered as initial trigger for the\nfibrinogenintofibrinandleadstothesubsequentclotformation", ". complement activation via the alternative or classical pathway\nTheactivationofcoagulationsystemisscreenedbydetection (GorbetandSefton,2004;Anderssonetal.,2005;Nilssonetal.,\nof FXIIa (Basu et al., 2017), prothrombin fragment 1 + 2 (F1 2007).Differentbiomaterialsurfacesshowdifferentcomplement\n+2)(Maitzetal.,2017;Sperlingetal.,2017),whichisreleased activatingproperties,forexample,hydrophobicsurfacescanlead\nduring thrombin formation, free active thrombin (Müller toanincreasedcomplementactivationcomparedtohydrophilic", "during thrombin formation, free active thrombin (Müller toanincreasedcomplementactivationcomparedtohydrophilic\net al., 2011), fibrinopeptide A (FPA) (Peckham et al., 1997), surfaces(Nilssonetal.,2007).\npartial thromboplastin time (PTT), or thrombin-antithrombin The generated complement activation products lead to the\nIII complex (TAT)", ". Furthermore, the degradation product of increased expression of P-selectin, which is an important\nfibrin, D-dimer, can be detected by ELISA to determine the mediator of neutrophil recruitment and platelet accumulation\nactivation of fibrinolysis (Sperling et al., 2017). Antithrombin (Sukavaneshvar,2017).ComparedtoC3aandC4a,theproduced\nIII inhibits thrombin by forming a TAT complex. Thus, this C5a is the most powerful anaphylatoxin", ". Thus, this C5a is the most powerful anaphylatoxin. It can increase the\ncomplex reflects a functional state of the coagulation system permeability of blood vessels, attract and activate neutrophil\nand can be quantified using ELISA. PTT assay measures the granulocytes and monocytes to stimulate phagocytosis. C5a\nclottingtimefromtheactivationofFactorXIItotheformation stimulates endothelial cells to increasingly express cytokines,\nof a stable fibrin clot", ". C5a\nclottingtimefromtheactivationofFactorXIItotheformation stimulates endothelial cells to increasingly express cytokines,\nof a stable fibrin clot. To detect PTT, citrated platelet-poor chemokines and cell adhesion molecules, such as E-selectin\nplasma is incubated at 37◦C with the test material for 15, 30, (Newton and Dixit, 2012). Furthermore, it can bind to mast\nor 60min", ". Furthermore, it can bind to mast\nor 60min. The addition of PTT reagent (cephalin) followed cellsandincreaseinflammation.Moreover,C5aisabletotrigger\nby the addition of calcium chloride solution inactivates the the release of TF from neutrophils and monocytes, which can\nanticoagulant and initiates clot formation and this time is initiatecoagulationcascade(Ikedaetal.,1997;Ritisetal.,2006;\nFrontiersinBioengineeringandBiotechnology|www.frontiersin.org 5 July2018|Volume6|Article99", "--- Page 6 ---\nWeberetal. HemocompatibilityofBlood-ContactingBiomaterials\nKourtzelisetal.,2010).Thus,thereisaclosecross-talkbetween further platelets passing by and lead to the adhesion and\nthe complement system and the coagulation pathway mediated aggregation of neighbored platelets. Finally, the thrombi is\nbythegeneratedC5a(Oikonomopoulouetal.,2010)", ". Finally, the thrombi is\nbythegeneratedC5a(Oikonomopoulouetal.,2010). stabilizedbyfibrin.Alphagranulescontainhemostaticproteins,\nTherefore, the analysis of complement activation is a highly suchasvWF,fibrinogen,FactorV,FactorIX,andplasminogen,\nrelevant criterion in the legislation for testing biomaterials chemokines (e.g., platelet factor 4 (PF4), SDF-1α), and growth\nintended for blood contact. According to ISO 10993-4 factors (e.g., VEGF, PDGF)", ". According to ISO 10993-4 factors (e.g., VEGF, PDGF). Furthermore, large amounts of β-\n(International Organization for Standardization, 2000), the thromboglobulin (β-TG) are released from alpha granules after\ncomplementactivationcanbeanalyzedbydetectionofC3a,C5a, the activation of platelets, which lead to leukocyte recruitment\nBb,iC3b,C4d,C3-,orC5-convertase,andtheC5b-9complexin (Brandtetal.,2000;Frohlich,2016).Inaddition,alphagranules\nwholeblood,aswellasthe50%complementhemolyticactivity also contain integral membrane protein P-selectin, which is\n(CH50) (Costabile, 2010)", ". Most frequently, the concentration translocated to the plasma membrane after the activation of\nofanaphylatoxinsC3aandC5aaswellastheC5b-9complexis platelets (Frenette et al., 2000). P-selectin glycoprotein ligand-1\ndeterminedusingELISA(Koppetal.,2002;Sperlingetal.,2007; (PSGL-1) expressed on leukocytes can interact with P-selectin\nEngbergetal.,2011).Furthermore,inarecentstudy,Endgberg and lead to the activation of neutrophils (Sreeramkumar et al.,\nandcolleaguesproposedthattheratiobetweenthebindingofC4 2014)", ". Furthermore, the released polyphosphates can activate\nand its inhibitor C4BP should be considered as a predictor for FactorXIIandleadtotheinitiationoftheintrinsiccoagulation\ntheevaluationofthehemocompatibility(Engbergetal.,2015)", ". pathway(Mülleretal.,2009).\nThe activation of platelets can be determined according to\nISO10993-4bymeasuringreleasedcontentsfromalphagranules,\nPLATELET ACTIVATION such as β-TG or PF4 using ELISA (Mayer et al., 2009; Teligui\netal.,2016;Stolletal.,2017)anddetectionofP-selectin(CD62P)\nPlatelets are present in large quantities in the blood and under oractivatedGPIIb/IIIareceptorwithPAC-1antibodyusingflow\nphysiological conditions, they circulate in a quiescent state for cytometry(Theoretetal.,2011;vanVelzenetal.,2012).\n7–10days.Theadhesionandactivationofplateletsisprevented", "7–10days.Theadhesionandactivationofplateletsisprevented\nby an healthy endothelial monolayer, which acts as a barrier\nbetweenbloodandtissuesandhasantithrombogenicproperties ACTIVATION OF LEUKOCYTES\nby the release of e.g., nitric oxide (NO) and prostaglandin I\n2\n(PGI )(Brassetal.,2013;GolebiewskaandPoole,2015;Frohlich, Besides coagulation, complement, and platelet activation, the\n2\n2016).Thedamageofendotheliumleadstotheexposureofthe activationofleukocytesandtheoccurrenceofrespiratoryburst\nunderlying subendothelial collagen to the blood", ". In addition, can be analyzed to evaluate biomaterial-induced inflammatory\ndamagedendothelialcellssecretevonWillebrandfactor(vWF), response.Thus,thegenerationofreactiveoxygenspecies(ROS)\nwhich can bind to the collagen in the exposed subendothelial and the release of PMN elastase are the mainly determined\nlayerandmediatetheadhesionofcirculatingplatelets(Yauetal., parametersforleukocytesactivation.Theactivationofleukocytes\n2015)toformasealatthedamagedarea", ". leadstoarespiratoryburst(DahlgrenandKarlsson,1999),which\nThe exposure of biomaterial to the blood can result in is the result of an enhanced oxygen metabolism, and results in\n−\nan undesired activation of platelets and consequently lead generationofROS(superoxide anion(O ),hydrogenperoxide\n2\nto thrombotic complications. Thus, the analysis of platelet (H O ),hydroxylradical(HO • )andsingletoxygen(1O ).Thus,\n2 2 2\nactivation is an important part of hemocompatibility tests", ". the ROS generation can be detected (Roesslein et al., 2013)\nThe contact of blood with foreign surfaces immediately leads using chemiluminogenic (Nygren et al., 2000) or fluorogenic\nto the adsorption of plasma proteins, especially fibrinogen, substances (Ferrer et al., 2013). Furthermore, the release of\nimmunoglobulins, fibronectin, vitronectin, Factor XI and XII, elastasefromPMNgranulocytes,especiallyfromneutrophils,can\nvWF, HMWK, and PK to the biomaterial surface (Long bequantifiedbyELISA(Zimmermannetal.,2007).Additionally,\net al., 2016)", ". Particularly, fibrinogen, vWF, fibronectin, and PMN elastase activity can also be measured by the proteolytic\nvitronectin induce the adhesion of platelets via interaction cleavageofasyntheticsubstrateandthereleaseofafluorophore,\nwith the most frequent integrin receptor α β glycoprotein whichcanbeeasilyquantifiedbyfluorescence(Gramegnaetal.,\nIIb 3\nIIb/IIIa (GPIIb/IIIa) on the surface of platelets and lead to the 2017).\nactivation of platelets. Subsequently, platelets release bioactive Theactivationofleukocytesleadstotheincreasedexpression\nmolecules from their alpha and dense granules", ". Subsequently, platelets release bioactive Theactivationofleukocytesleadstotheincreasedexpression\nmolecules from their alpha and dense granules. Each platelet of CD11b on the cell surface via translocation of the CD11b\ncontains ∼50–80 alpha granules and ∼3–6 dense granules from intracellular granules to the plasma membrane. Thus, the\n(Fitch-Tewfik and Flaumenhaft, 2013)", ". Thus, the\n(Fitch-Tewfik and Flaumenhaft, 2013). The dense granules detectionofCD11bexpressiononthesurfaceofleukocytesusing\ncontain proaggregatory factors such as adenosine diphosphate fluorescence-activated cell sorting (FACS) can give additional\n(ADP), adenosine triphosphate (ATP), histamine, serotonin information on activation of leukocytes (Gorbet et al., 1999).\n[5-hydroxytryptamine (5-HT)], polyphosphates, and bivalent Furthermore, the production of neutrophil extracellular traps\ncations\nMg2+\nand\nCa2+\n(Meyers et al., 1982)", ". ADP can (NETs) is a recently described mechanism of neutrophils for\nactivate neighboring platelets via binding to two different host defense (Brinkmann et al., 2004; Delgado-Rizo et al.,\npurinergic receptors on platelets, known as P2Y and P2Y 2017).DuringNETosis,thenuclearmaterialisreleasedinform\n1 12\n(WijeyeratneandHeptinstall,2011).Theseplateletscanactivate of a meshwork of chromatin by activated neutrophils to the\nFrontiersinBioengineeringandBiotechnology|www.frontiersin.org 6 July2018|Volume6|Article99", "--- Page 7 ---\nWeberetal. HemocompatibilityofBlood-ContactingBiomaterials\nFIGURE3|Scanningelectronmicroscopic(SEM)analysisofsyntheticvasculargraftsurfaceafterthebloodcontact.Arrowsindicatetheadheredplateletsaswellas\ntheresulting3D-fibrinmeshesduetoactivationofbloodcoagulation.Theanalyseswereperformedinourworkinggroupandthedatahasnotbeenpublishedbefore.\nextracellular space (Noubouossie et al., 2017)", ". Several proteins release of vasoconstrictive substances, such as thromboxane\nadhere to the NETs, such as histones and components with and PDGF, as well as contents of stored granules occur.\nantimicrobialactivity,e.g.,elastaseandmyeloperoxide(Delgado- Finally, the aggregation of platelets and the generation of\nRizoetal.,2017).Besidestheabilitytotrapbacteria,NETsability a fibrin network can be analyzed using scanning electron\ntopromotethrombosiswasdemonstratedinanimalmodels(Brill microscopy (SEM) (Zhang et al., 2017) (Figure3). Thus, in\netal.,2012)", ". several studies, the surface thrombogenicity of biomaterials\nwas examined by characterization of cell morphology and\nANALYSIS OF BIOMATERIAL SURFACES spreadingusingSEM(BalasubramanianandSlack,2001;Aguilar\netal.,2002).Furthermore,usingfluorescentlylabeledantibodies\nThe adsorption of proteins to the surface of biomaterials is the against specific receptors, the adhered cells and the cell density\ninitialstepdirectlyafterthebloodcontact.Subsequently,adhered can be detected using fluorescence and confocal microscopy", "initialstepdirectlyafterthebloodcontact.Subsequently,adhered can be detected using fluorescence and confocal microscopy\nproteins initiate the adhesion and activation of platelets on the (Nguyenetal.,2016).Inrecentyears,microgravimetricanalyses\nsurface.Theseplateletscanfurtheractivateneighboredplatelets using quartz crystal microbalance (QCM) were also applied to\nandatthelaststepthethrombiarestabilizedbythegenerationof investigatetheplateletadhesionandactivation(Sinnetal.,2010;\nafibrinnetwork", ". Fatisson et al., 2011; Kunze et al., 2014). Moreover, Hanson\nThe activation of platelets is a very fast process of ∼180ms and colleagues used surface plasmon resonance (SPR) based\n(van Oeveren, 2013) and different morphological appearance flow chamber device to detect platelet-surface interactions and\nof platelets can be detected on material surfaces depending on blood coagulation (Hansson et al., 2007). Furthermore, Zhao\nvarying states of activation: (1) unactivated platelets: round, et al", ". (2011) used SEM and transmission electron microscopy\ndiscoid shaped without pseudopodia, (2) partially activated (TEM)toinvestigatetheeffectofdifferentsizesofnanoparticles\nplatelets: dendritic with early pseudopodia, (3) moderately on hemolysis and the mechanism behind the lysis of red\nactivated platelets: spread-dendritic with irreversible long- bloodcells.Thegroupdemonstratedthatasmallproportionof\ndendritic extensions, (4) fully activated platelets: fully spread smalltypeofmesoporoussilicananoparticles(MSNs)adsorbed\n(Parketal.,1990)", ". to the surface of erythrocytes without any alteration of cell\nTheadhesionandactivationofplateletsleadtoacytoskeletal membrane or morphology. In contrast, the adsorption of large\nrearrangement and therefore to a morphological change of typeMSNstotheerythrocytesinducedastronglocalmembrane\nplatelets on the biomaterial surface with extensive formation deformation and resulted in internalization of particles and\nof pseudopodia. Afterwards, the spreading of platelets and the hemolysis.\nFrontiersinBioengineeringandBiotechnology|www.frontiersin.org 7 July2018|Volume6|Article99", "--- Page 8 ---\nWeberetal. HemocompatibilityofBlood-ContactingBiomaterials\nCONCLUSION hemocompatibility. Furthermore, to prove the safety and\nreliability of new products, hemocompatibility analyses should\nThe interaction of biomaterials with blood leads to cellular include appropriate references and follow the ISO 10993-4\nas well as humoral reactions, which can result in an standard.\nunwanted inflammation and activation of coagulation and/or\nfibrinolysis", ". Thus, the development of biomaterials with an AUTHOR CONTRIBUTIONS\nimproved hemocompatibility increases the tolerability and\nminimizes unwanted side effects, such as thrombus formation. MA-A is the corresponding author of this work. She\nTherefore, during the development of new blood-contacting developed the outline with HW and CS edited the paper.\nmedical devices, not only the mechanical and chemical MWandMA-Awrotethemanuscript.HS,SG,andLHrevised\ncharacteristics should play an important role, but also the themanuscript.\nREFERENCES\nCerda-Cristerna, B", ". I., Flores, H., Pozos-Guillén, A., Pérez, E., Sevrin, C., and\nGrandfils,C.(2011).Hemocompatibilityassessmentofpoly(2-dimethylamino\nAguilar,M.R.,Rodríguez,G.,Fernández,M.,Gallardo,A.,andSanRomán,J. ethylmethacrylate)(PDMAEMA)-based polymers. J. Control. Release 153,\n(2002).Polymericactivecoatingswithfunctionalityinvascularapplications. 269–277.doi:10.1016/j.jconrel.2011.04.016\nJ. Mater. Sci. Mater. Med. 13, 1099–1104. doi: 10.1023/A:10211009 Costabile,M.(2010).Measuringthe50%haemolyticcomplement(CH50)activity\n16920 ofserum.J.Vis.Exp.37:1923.doi:10.3791/1923\nAndersson, J., Ekdahl, K", ". N., Lambris, J. D., and Nilsson, B. (2005). Binding Dahlgren,C.,andKarlsson,A.(1999).Respiratoryburstinhumanneutrophils.J.\nof C3 fragments on top of adsorbed plasma proteins during complement Immunol.Methods.232,3–14.\nactivation on a model biomaterial surface. Biomaterials 26, 1477–1485. Delgado-Rizo, V., Martínez-Guzmán, M", ". Biomaterials 26, 1477–1485. Delgado-Rizo, V., Martínez-Guzmán, M. A., Iñiguez-Gutierrez, L., García-\ndoi:10.1016/j.biomaterials.2004.05.011 Orozco,A.,Alvarado-Navarro,A.,andFafutis-Morris,M.(2017).Neutrophil\nBae,S.W.,Kim,H.S.,Cha,Y.N.,Park,Y.S.,Jo,S.A.,andJo,I.(2003).Rapid extracellulartrapsanditsimplicationsininflammation:anoverview.Front.\nincreaseinendothelialnitricoxideproductionbybradykininismediatedby Immunol.8:81.doi:10.3389/fimmu.2017.00081\nprotein kinase A signaling pathway. Biochem. Biophys. Res. Commun", ". Biochem. Biophys. Res. Commun. 306, Dunkelberger,J.R.,andSong,W.-C.(2010).Complementanditsroleininnate\n981–987.doi:10.1016/S0006-291X(03)01086-6 andadaptiveimmuneresponses.CellRes.20,34–50.doi:10.1038/cr.2009.139.\nBalasubramanian, V., and Slack, S. M. (2001). Effects of fibrinogen residence Engberg,A.E.,Nilsson,P.H.,Huang,S.,Fromell,K.,Hamad,O.A.,Mollnes,T.E.,\ntime and shear rate on the morphology and procoagulant activity of etal.(2015).Predictionofinflammatoryresponsesinducedbybiomaterialsin\nhumanplateletsadherenttopolymericbiomaterials.ASAIOJ.47,354–360", ". contactwithhumanbloodusingproteinfingerprintfromplasma.Biomaterials\ndoi:10.1097/00002480-200107000-00012 36,55–65.doi:10.1016/j.biomaterials.2014.09.011\nBallet,T.,Boulange,L.,Brechet,Y.,Bruckert,F.,andWeidenhaupt,M.(2010). Engberg,A.E.,Rosengren-Holmberg,J.P.,Chen,H.,Nilsson,B.,Lambris,J.D.,\nProteinconformationalchangesinducedbyadsorptionontomaterialsurfaces: Nicholls,I.A.,etal.(2011).Bloodprotein-polymeradsorption:implicationsfor\nanimportantissueforbiomedicalapplicationsofmaterialscience.Bull.Pol", ". understandingcomplement-mediatedhemoincompatibility.J.Biomed.Mater.\nAcad.Sci.Tech.Sci.58,303–313.doi:10.2478/v10175-010-0028-0 Res.A97,74–84.doi:10.1002/jbm.a.33030\nBasu, A., Hong, J., and Ferraz, N. (2017). Hemocompatibility of Ca(2+) Fatisson, J., Mansouri, S., Yacoub, D., Merhi, Y., and Tabrizian, M", ". (2017). Hemocompatibility of Ca(2+) Fatisson, J., Mansouri, S., Yacoub, D., Merhi, Y., and Tabrizian, M. (2011).\n-crosslinked nanocellulose hydrogels: toward efficient management of Determination of surface-induced platelet activation by applying\nhemostasis.Macromol.Biosci.17.doi:10.1002/mabi.201700236 time-dependency dissipation factor versus frequency using quartz\nBiró,E.K.,Sturk-Maquelin,Vogel,G.,Meuleman,D.,Smit,M.,Hack,C.,etal. crystal microbalance with dissipation. J. R. Soc", ". crystal microbalance with dissipation. J. R. Soc. Interface 8, 988–997.\n(2003).Humancell-derivedmicroparticles promotethrombusformationin doi:10.1098/rsif.2010.0617\nvivoinatissuefactor-dependentmanner.J.Thromb.Haemost.1,2561–2568. Ferrer,M.C.,Eckmann,U.N.,Composto,R.J.,andEckmann,D.M.(2013).\ndoi:10.1046/j.1538-7836.2003.00456.x Hemocompatibility and biocompatibility ofantibacterial biomimetic hybrid\nBlok, L. J. S., Engels, G. E., and van Oeveren, W. (2016)", ". J. S., Engels, G. E., and van Oeveren, W. (2016). In vitro films.Toxicol.Appl.Pharmacol.272,703–712.doi:10.1016/j.taap.2013.07.023\nhemocompatibility testing: the importance of fresh blood. Biointerphases Fitch-Tewfik, J. L., and Flaumenhaft, R. (2013). Platelet granule exocytosis:\n11:029802.doi:10.1116/1.4941850 a comparison with chromaffin cells. Front. Endocrinol. (Lausanne) 4:77.\nBrandt,E.,Petersen,F.,Ludwig,A.,Ehlert,J.E.,Bock,L.,andFlad,H.D.(2000)", ". Front. Endocrinol. (Lausanne) 4:77.\nBrandt,E.,Petersen,F.,Ludwig,A.,Ehlert,J.E.,Bock,L.,andFlad,H.D.(2000). doi:10.3389/fendo.2013.00077\nThebeta-thromboglobulinsandplateletfactor4:bloodplatelet-derivedCXC Frenette,P.S.,Denis,C.V.,Weiss,L.,Jurk,K.,Subbarao,S.,Kehrel,B.,etal.\nchemokineswithdivergentrolesinearlyneutrophilregulation.J.Leukoc.Biol. (2000).P-Selectinglycoproteinligand1(PSGL-1)isexpressedonplateletsand\n67,471–478.doi:10.1002/jlb.67.4.471 canmediateplatelet-endothelialinteractionsinvivo.J.Exp.Med.191,1413–22.\nBrass, L. F., Tomaiuolo, M., and Stalker, T. J. (2013)", ". F., Tomaiuolo, M., and Stalker, T. J. (2013). Harnessing the platelet doi:10.1084/jem.191.8.1413\nsignalingnetworktoproduceanoptimalhemostaticresponse.Hematol.Oncol. Frohlich, E. (2016). Action of nanoparticles on platelet activation\nClin.NorthAm.27,381–409.doi:10.1016/j.hoc.2013.02.002 and plasmatic coagulation, Curr. Med. Chem. 23, 408–430.\nBraune, S., Grunze, M., Straub, A., and Jung, F. (2013). Are there sufficient doi:10.2174/0929867323666160106151428\nstandards for the in vitro hemocompatibility testing of biomaterials?. Golebiewska, E. M., and Poole, A. W. (2015)", ". Golebiewska, E. M., and Poole, A. W. (2015). Platelet secretion: from\nBiointerphases8:33.doi:10.1186/1559-4106-8-33 haemostasis to wound healing and beyond. Blood Rev. 29, 153–162.\nBrill,A.,Fuchs,T.,Savchenko,A.,Thomas,G.,Martinod,K.,DeMeyer,S.,etal. doi:10.1016/j.blre.2014.10.003\n(2012).Neutrophilextracellulartrapspromotedeepveinthrombosisinmice.J", ". doi:10.1016/j.blre.2014.10.003\n(2012).Neutrophilextracellulartrapspromotedeepveinthrombosisinmice.J. Gorbet,M.B.,andSefton,M.V(2004).Biomaterial-associatedthrombosis:roles\nThromb.Haemost.10,136–144.doi:10.1111/j.1538-7836.2011.04544.x ofcoagulationfactors,complement,plateletsandleukocytes.Biomaterials25,\nBrinkmann,V.,Reichard,U.,Goosmann,C.,Fauler,B.,Uhlemann,Y.,Weiss,D.S., 5681–703.doi:10.1016/j.biomaterials.2004.01.023\netal.(2004)Neutrophilextracellulartrapskillbacteria.Science303,1532–1535. Gorbet, M., Yeo, E., and Sefton, M. (1999)", ". Gorbet, M., Yeo, E., and Sefton, M. (1999). Flow cytometric study of in vitro\ndoi:10.1126/science.1092385 neutrophilactivationbybiomaterials.J.Biomed.Mater.Res.A44,289–297.\nCamci-Unal, G., Cuttica, D., Annabi, N., Demarchi, D., and Khademhosseini, Gramegna, A., Amati, F., Terranova, L., Sotgiu, G., Tarsia, P., Miglietta, D.,\nA. (2013). Synthesis and characterization of hybrid hyaluronic acid-gelatin et al. (2017). Neutrophil elastase in bronchiectasis. Respir. Res", ". (2013). Synthesis and characterization of hybrid hyaluronic acid-gelatin et al. (2017). Neutrophil elastase in bronchiectasis. Respir. Res. 18:211.\nhydrogels.Biomacromolecules14,1085–1092.doi:10.1021/bm3019856 doi:10.1186/s12931-017-0691-x\nFrontiersinBioengineeringandBiotechnology|www.frontiersin.org 8 July2018|Volume6|Article99", "--- Page 9 ---\nWeberetal. HemocompatibilityofBlood-ContactingBiomaterials\nHansson,K.M.,Johansen,K.,Wetterö,J.,Klenkar,G.,Benesch,J.,Lundström, Mayer,A.,Vadon,M.,Rinner,B.,Novak,A.,Wintersteiger,R.,andFrohlich,E.\nI., et al. (2007). Surface plasmon resonance detection of blood coagulation (2009).Theroleofnanoparticlesizeinhemocompatibility. Toxicology 258,\nand platelet adhesion under venous and arterial shear conditions. Biosens. 139–147.doi:10.1016/j.tox.2009.01.015\nBioelectron.23,261–268.doi:10.1016/j.bios.2007.04.009 McClung, W. G., Babcock, D., and Brash, J. (2007)", ". 139–147.doi:10.1016/j.tox.2009.01.015\nBioelectron.23,261–268.doi:10.1016/j.bios.2007.04.009 McClung, W. G., Babcock, D., and Brash, J. (2007). Fibrinolytic properties of\nHaycox, C.L.,and Ratner,B.D(1993).In vitroplatelet interactions inwhole lysine-derivatizedpolyethyleneincontactwithflowingwholeblood(Chandler\nhumanbloodexposedtobiomaterialsurfaces:insightsonbloodcompatibility. loop model). J. Biomed. Mater. Res. A 81, 644–651. doi: 10.1002/jbm.a.\nJ.Biomed.Mater.Res.A27,1181–1193. 31018\nInternational Organization for Standardization (2000)", ". Biomed. Mater. Res. A 81, 644–651. doi: 10.1002/jbm.a.\nJ.Biomed.Mater.Res.A27,1181–1193. 31018\nInternational Organization for Standardization (2000). Biological Evaluation of Meyers,K.M.,Holmsen,H.,andSeachord,C.L.(1982).Comparativestudyof\nMedicalDevices.Availableonlineathttps://www.iso.org/standard/63448.html plateletdensegranuleconstituents.Am.J.Physiol.243,R454–R461.\n(AccessedApril23,2018). Millar, J. E., Fanning, J. P., McDonald, C. I., McAuley, D. F., and Fraser,\nIkeda,K.,Nagasawa,K.,Horiuchi,T.,Tsuru,T.,Nishizaka,H.,andNiho,Y.(1997). J. F. (2016)", ". P., McDonald, C. I., McAuley, D. F., and Fraser,\nIkeda,K.,Nagasawa,K.,Horiuchi,T.,Tsuru,T.,Nishizaka,H.,andNiho,Y.(1997). J. F. (2016). The inflammatory response to extracorporeal membrane\nC5ainducestissuefactoractivityonendothelialcells.Thromb.Haemost.77, oxygenation (ECMO): a review of the pathophysiology. Crit. Care 20:387.\n394–398. doi:10.1186/s13054-016-1570-4\nKälsch, T., Elmas, E., Nguyen, X. D., Suvajac, N., Klüter, H., Borggrefe, Mohan,C.C.,Chennazhi,K.P.,andMenon,D.(2013).Invitrohemocompatibility\nM. et al. (2007)", ". D., Suvajac, N., Klüter, H., Borggrefe, Mohan,C.C.,Chennazhi,K.P.,andMenon,D.(2013).Invitrohemocompatibility\nM. et al. (2007). Endotoxin-induced effects on platelets and monocytes and vascular endothelial cell functionality on titania nanostructures under\nin an in vivo model of inflammation. Basic Res. Cardiol. 102, 460–466. staticanddynamicconditionsforimprovedcoronarystentingapplications.\ndoi:10.1007/s00395-007-0667-y ActaBiomater.9,9568–9577.doi:10.1016/j.actbio.2013.08.023\nKappelmayer,J.,Bernabei,A.,Edmunds,L.H.,Edgington,T.S.,andColman, Müller, F., Mutch, N. J., Schenk, W. A., Smith, S", ". J., Schenk, W. A., Smith, S. A., Esterl, L., Spronk,\nR. W. (1993). Tissue factor is expressed on monocytes during simulated H. M., et al. (2009). Platelet polyphosphates are proinflammatory and\nextracorporealcirculation.Circ.Res.72,1075–1081. procoagulantmediatorsinvivo.Cell139,1143–1156.doi:10.1016/j.cell.2009.\nKent, N. J., Basabe-Desmonts, L., Meade, G., MacCraith, B. D., Corcoran, B. 11.001\nG., Kenny, D., et al. (2010)", ". J., Basabe-Desmonts, L., Meade, G., MacCraith, B. D., Corcoran, B. 11.001\nG., Kenny, D., et al. (2010). Microfluidic device to study arterial shear- Müller, J., Becher, T., Braunstein, J., Berdel, P., Gravius, S., Rohrbach,\nmediatedplatelet-surfaceinteractionsinwholeblood:reducedsamplevolumes F., et al. (2011). Profiling of active thrombin in human blood by\nandwell-characterisedproteinsurfaces.Biomed.Microdevices12,987–1000. supramolecular complexes. Angew. Chem. Int. Ed. Engl. 50, 6075–6078.\ndoi:10.1007/s10544-010-9453-y", ". supramolecular complexes. Angew. Chem. Int. Ed. Engl. 50, 6075–6078.\ndoi:10.1007/s10544-010-9453-y. doi:10.1002/anie.201007032\nKopp,R.,Mottaghy,K.,andKirschfink,M.(2002).Mechanismofcomplement Müller, M., Krolitzki, B., and Glasmacher, B. (2012). Dynamic in vitro\nactivation during extracorporeal blood-biomaterial interaction: effects hemocompatibilitytesting–improvingthesignaltonoiseratio.Biomed.Eng.\nof heparin coated and uncoated surfaces. ASAIO J. 48, 598–605. 57,549–552.doi:10.1515/bmt-2012-4211\ndoi:10.1097/00002480-200211000-00005 Nagy, M., Heemskerk, J. W., and Swieringa, F. (2017)", ". ASAIO J. 48, 598–605. 57,549–552.doi:10.1515/bmt-2012-4211\ndoi:10.1097/00002480-200211000-00005 Nagy, M., Heemskerk, J. W., and Swieringa, F. (2017). Use of microfluidics\nKourtzelis, I., Markiewski, M. M., Doumas, M., Rafail, S., Kambas, to assess the platelet-based control of coagulation. Platelets 28, 441–448.\nK., Mitroulis, I., et al. (2010). Complement anaphylatoxin C5a doi:10.1080/09537104.2017.1293809\ncontributes to hemodialysis-associated thrombosis. Blood 116, 631–639. Neun, B. W., and Dobrovolskaia, M. A. (2011)", ". Blood 116, 631–639. Neun, B. W., and Dobrovolskaia, M. A. (2011). “Method for analysis\ndoi:10.1182/blood-2010-01-264051 of nanoparticle hemolytic properties in vitro,” in Characterization of\nKovach, K. M., Capadona, J. R., Gupta, A. S., and Potkay, J. A. (2014). Nanoparticles Intended for Drug Delivery (Humana Press), 215–224.\nThe effects of PEG-based surface modification of PDMS microchannels on doi:10.1007/978-1-60327-198-1\nlong-term hemocompatibility. J. Biomed. Mater. Res. A 102, 4195–4205. Newton, K., and Dixit, V. M. (2012)", ". J. Biomed. Mater. Res. A 102, 4195–4205. Newton, K., and Dixit, V. M. (2012). Signaling in innate immunity\ndoi:10.1002/jbm.a.35090 and inflammation. Cold Spring Harb. Perspect. Biol. 4:a006049.\nKrajewski, S., Prucek, R., Panacek, A., Avci-Adali, M., Nolte, A., Straub, A., doi:10.1101/cshperspect.a006049.\net al. (2013)", ". (2013). Hemocompatibility evaluation of different silver nanoparticle Nilsson,B.,Ekdahl,K.N.,Mollnes,T.E.,andLambris,J.D.(2007).Theroleof\nconcentrationsemployingamodifiedChandler-loopinvitroassayonhuman complementinbiomaterial-inducedinflammation.Mol.Immunol.44,82–94.\nblood.ActaBiomater.9,7460–7468.doi:10.1016/j.actbio.2013.03.016 doi:10.1016/j.molimm.2006.06.020\nKuhbier, J., Coger, V., Mueller, J., Liebsch, C., Schlottmann, F., Bucan, V., Nguyen, T.-H., Palankar, V.-R., Bui, C., Medvedev, N., Greinacher, A.,\net al. (2017)", ". (2017). Influence of direct or indirect contact for the cytotoxicity and Delcea, M. (2016). Rupture forces among human blood platelets\nand blood compatibility of spider silk. J. Mater. Sci. Mater. Med. 28:127. at different degrees of activation. Sci. Rep. 6:25402. doi: 10.1038/srep\ndoi:10.1007/s10856-017-5936-1 25402\nKunze,A.,Hesse,C.,andSvedhem,S.(2014).Real-timemonitoringofsurface- Nordling,S.,Nilsson,B.,andMagnusson,P.U(2014).Anovelinvitromodelfor\nconfinedplateletactivationonTio2.ColloidsSurf.BBiointerfaces116,446–451", ". studyingtheinteractionsbetweenhumanwholebloodandendothelium.J.Vis.\ndoi:10.1016/j.colsurfb.2014.01.025 Exp.96:e52112.doi:10.3791/52112\nLackner, J. M., Waldhauser, W., Hartmann, P., Bruckert, F., Weidenhaupt, Noubouossie, D. F., Whelihan, M. F.,Yu, Y.-B., Sparkenbaugh, E.,\nM.,Major,R.,etal.(2012).Hemocompatibilityofinorganicphysicalvapor Pawlinski, R., and Key, N. (2017). In vitro activation of coagulation\ndeposition(PVD)coatingsonthermoplasticpolyurethanepolymers.J.Funct. by human neutrophil DNA and histone proteins but not neutrophil\nBiomater.3,283–297.doi:10.3390/jfb3020283", ". by human neutrophil DNA and histone proteins but not neutrophil\nBiomater.3,283–297.doi:10.3390/jfb3020283. extracellular traps. Blood 129, 1021–1029. doi: 10.1182/blood-2016-06-7\nLi, Y., and Boraschi, D. (2016). Endotoxin contamination: a key element 22298\nin the interpretation of nanosafety studies. Nanomedicine 11, 269–287. Nygren, H., Braide, M., and Karlsson, C. (2000). Different kinetics of the\ndoi:10.2217/nnm.15.196 respiratory burst response in granulocytes, induced by serum from blood\nLiu, X., Yuan, L., Li, D., Tang, Z., Wang, Y., Chen, G., et al. (2014)", ". (2014). Blood coagulated in contact with polymer materials. Biomaterials 21, 173–182.\ncompatible materials: state of the art. J. Mater. Chem. B 2, 5718–5738. doi:10.1016/S0142-9612(99)00146-5\ndoi:10.1039/C4TB00881B Oikonomopoulou, K., Ricklin, D., Ward, P. A., and Lambris, J.\nLong, A. T., Kenne, E., Jung, R., Fuchs, T. A., and Renné, T. (2016). Contact D. (2010). Interactions between coagulation and complement—\nsystemrevisited:aninterfacebetweeninflammation,coagulation,andinnate their role in inflammation. Semin. immunopathol", ". Semin. immunopathol. 34, 151–165.\nimmunity.J.Thromb.Haemost.14,427–437.doi:10.1111/jth.13235 doi:10.1007/s00281-011-0280-x.\nMagalhães, P. O., Lopes, A. M., Mazzola, P. G., Rangel-Yagui, C., Penna, T., Onasoga-Jarvis, A., Puls, T., O’brien, S., Kuang, L., Liang, H., and Neeves,\nand Pessoa, A. Jr. (2007). Methods of endotoxin removal from biological K. (2014). Thrombin generation and fibrin formation under flow on\npreparations:areview.J.Pharm.Pharm.Sci.10,388–404. biomimetic tissue factor-rich surfaces. J. Thromb. Haemost. 12, 373–382.\nMaitz, M", ". biomimetic tissue factor-rich surfaces. J. Thromb. Haemost. 12, 373–382.\nMaitz, M. F., Sperling, C., Wongpinyochit, T., Herklotz, M., Werner, C., doi:10.1111/jth.12491\nand Seib, F. P. (2017)", ". Haemost. 12, 373–382.\nMaitz, M. F., Sperling, C., Wongpinyochit, T., Herklotz, M., Werner, C., doi:10.1111/jth.12491\nand Seib, F. P. (2017). Biocompatibility assessment of silk nanoparticles: Onasoga-Jarvis,A.A.,Leiderman,K.,Fogelson,A.L.,Wang,M.,Manco-Johnson,\nhemocompatibilityandinternalizationbyhumanbloodcells.Nanomedicine13, M.J.,DiPaola,J.A.,etal.(2013).TheeffectoffactorVIIIdeficienciesand\n2633–2642.doi:10.1016/j.nano.2017.07.012 replacementandbypasstherapiesonthrombusformationundervenousflow\nFrontiersinBioengineeringandBiotechnology|www.frontiersin.org 9 July2018|Volume6|Article99", "--- Page 10 ---\nWeberetal. HemocompatibilityofBlood-ContactingBiomaterials\nconditions inmicrofluidic and computational models. PLoS ONE 8:e78732. Teligui, L., Dalmayrac, E., Corbeau, J. J., Bouquet, E., Godon, A., Denomme,\ndoi:10.1371/journal.pone.0078732 A. S., et al. (2016). Ex vivo simulation of cardiopulmonary bypass\nPark,K.,Mao,F.,andPark,H.(1990).Morphologicalcharacterizationofsurface- with human blood for hemocompatibility testing. Perfusion 31, 376–83.\ninducedplateletactivation.Biomaterials11,24–31. doi:10.1177/0267659115599454\nPeckham, S. M., Turitto, V", ". Perfusion 31, 376–83.\ninducedplateletactivation.Biomaterials11,24–31. doi:10.1177/0267659115599454\nPeckham, S. M., Turitto, V. T., Glantz, J., Puryear, H., and Slack, S. (1997). Théorêt, J. F., Yacoub, D., Hachem, A., Gillis, M. A., and Merhi, Y.\nHemocompatibility studies of surface-treated polyurethane-based chronic (2011). P-selectin ligation induces platelet activation and enhances\nindwellingcatheters.J.Biomater.Sci.8,847–858. microaggregate and thrombus formation. Thromb. Res. 128, 243–50.\nPodias, A., Groth, T., and Missirlis, Y. (1995)", ". microaggregate and thrombus formation. Thromb. Res. 128, 243–50.\nPodias, A., Groth, T., and Missirlis, Y. (1995). The effect of shear rate on the doi:10.1016/j.thromres.2011.04.018.\nadhesion/activationofhumanplateletsinflowthroughaclosed-looppolymeric Thorsen, T., Klausen, H., Lie, R., and Holmsen, H. (1993) Bubble-induced\ntubularsystem.J.Biomater.Sci.6,399–410", ". (1993) Bubble-induced\ntubularsystem.J.Biomater.Sci.6,399–410. aggregationofplatelets:effectsofgasspecies,proteins,anddecompression.\nPunet,X.,Mauchauffé,R.,Rodríguez-Cabello,J.C.,Alonso,M.,Engel,E.,and UnderseaHyperb.Med.20,101–119.\nMateos-Timoneda,M.A.(2015).Biomolecularfunctionalizationforenhanced Tiffany,C.W.,andBurch,R.M.(1989).Bradykininstimulatestumornecrosis\ncell–material interactions of poly (methyl methacrylate) surfaces. Regen", ". Regen. factorandinterleukin-1releasefrommacrophages.FEBSLett.247,189–192.\nBiomater.2,167–175.doi:10.1093/rb/rbv014 Totea, G., Ionita, D., Demetrescu, I., and Mitache, M. (2014). In vitro\nQian, Q., Nath, K. A., Wu, Y., Daoud, T. M., and Sethi, S. (2010). hemocompatibilityandcorrosionbehaviorofnewZr-binaryalloysinwhole\nHemolysis and acute kidney failure. Am. J. Kidney Dis. 56, 780–784", ". (2010). hemocompatibilityandcorrosionbehaviorofnewZr-binaryalloysinwhole\nHemolysis and acute kidney failure. Am. J. Kidney Dis. 56, 780–784. humanblood.OpenChem.12,796–803.doi:10.2478/s11532-014-0535-1\ndoi:10.1053/j.ajkd.2010.03.025 VafaHomann,M.,Johansson,D.,Wallen,H.,andSanchez,J.(2016).Improved\nRitis,K.,Doumas,M.,Mastellos,D.,Micheli,A.,Giaglis,S.,Magotti,P.,etal. ex vivo blood compatibility of central venous catheter with noble metal\n(2006). A novel C5a receptor-tissue factor cross-talk in neutrophils links alloy coating. J. Biomed. Mater. Res. B Appl. Biomater", ". A novel C5a receptor-tissue factor cross-talk in neutrophils links alloy coating. J. Biomed. Mater. Res. B Appl. Biomater. 104, 1359–1365.\ninnate immunity to coagulation pathways. J. Immunol. 177, 4794–4802. doi:10.1002/jbm.b.33403\ndoi:10.4049/jimmunol.177.7.4794 VanKruchten,R.,Cosemans,J.M.,andHeemskerk,J.W.(2012).Measurement\nRitz-Timme,S.,Eckelt,N.,Schmidtke,E.,andThomsen,H.(1997).Genesisand of whole blood thrombus formation using parallel-plate flow chambers–\ndiagnosticvalueofleukocyteandplateletaccumulationsaround“airbubbles” a practical guide. Platelets 23, 229–242", ". Platelets 23, 229–242. doi: 10.3109/09537104.2011.6\ninbloodaftervenousairembolism.Int.J.Leg.Med.111,22–26. 30848\nRoesslein, M., Hirsch, C., Kaiser, J.-P., Krug, H. F., and Wick, P. (2013). van Oeveren, W. (2013). Obstacles in haemocompatibility testing. Scientifica\nComparabilityofinvitrotestsforbioactivenanoparticles:acommonassayto 2013:392584.doi:10.1155/2013/392584\ndetectreactiveoxygenspeciesasanexample.Int.J.Mol.Sci.14,24320–24337", ". VanOeveren,W.,Tielliu,I.F.,andDeHart,J.(2012).Comparisonofmodified\ndoi:10.3390/ijms141224320 chandler,rollerpump,andballvalvecirculationmodelsforinvitrotesting\nSanak,M,Jakieła,B.,andWegrzyn,W.(2010).Assessmentofhemocompatibility in high blood flow conditions: application in thrombogenicity testing of\nofmaterialswitharterialbloodflowbyplateletfunctionaltests.Bull.Polish different materials for vascular applications. Int. J. Biomater. 2012:673163.\nAcad.Sci.Tech.Sci.58,317–322.doi:10.2478/v10175-010-0029-z doi:10.1155/2012/673163\nSchrottmaier, W. C., Kral, J", ". Int. J. Biomater. 2012:673163.\nAcad.Sci.Tech.Sci.58,317–322.doi:10.2478/v10175-010-0029-z doi:10.1155/2012/673163\nSchrottmaier, W. C., Kral, J. B., Zeitlinger, M., Salzmann, M., Jilma, B., and van Velzen, J. F., Laros-van Gorkom, Pop, G. A., and van Heerde,\nAssinger,A.(2016).Plateletactivationattheonsetofhumanendotoxemiais W. L. (2012). Multicolor flow cytometry for evaluation of platelet\nundetectableinvivo.Platelets27,479–483.doi:10.3109/09537104.2015 surface antigens and activation markers. Thromb. Res", ". Thromb. Res. 130,92–98.\nSinn, S., Müller, L., Drechsel, H., Wandel, M., Northoff, H., Ziemer, G., et al. doi:10.1016/j.thromres.2012.02.041\n(2010).Plateletaggregationmonitoringwithanewlydevelopedquartzcrystal Vroman,L.,Adams,A.L,Fischer,G.C.,andMunoz,P.C.(1980).Interaction\nmicrobalancesystemasanalternativetoopticalplateletaggregometry.Analyst ofhighmolecularweightkininogen,factorXII,andfibrinogeninplasmaat\n135,2930–2938.doi:10.1039/c0an00474j interfaces.Blood55,156–159.\nSinn,S.,Scheuermann,T.,Deichelbohrer,S.,Ziemer,G.,andWendel,H.P.(2011)", ". Wachtfogel,Y.T.,Hack,C.E.,Nuijens,J.,Kettner,C.,Reilly,T.M.,Knabb,R.\nA novel in vitro model for preclinical testing of the hemocompatibility of M.,etal.(1995).Selectivekallikreininhibitorsalterhumanneutrophilelastase\nintravascularstentsaccordingtoISO10993-4.J.Mater.Sci.Mater.Med.22, releaseduringextracorporealcirculation.Am.J.Physiol.268,H1352–H1357.\n1521–1528.doi:10.1007/s10856-011-4335-2 Wang,D.-A.,Ji,J.,Gao,C.-Y.,Yu,G.-H.,andFeng,L.-X.(2001)Surfacecoating\nSperling, C., Maitz, M. F., Grasso, S., Werner, C., and Kanse, S. M. (2017)", ". F., Grasso, S., Werner, C., and Kanse, S. M. (2017). of stearyl poly (ethylene oxide) coupling-polymer on polyurethane guiding\nA positively charged surface triggers coagulation activation through factor catheters with poly (ether urethane) film-building additive for biomedical\nVIIactivatingprotease(FSAP).ACSAppl.Mater.Interfaces9,40107–40116. applications. Biomaterials 22, 1549–1562. doi: 10.1016/S0142-9612(00)00\ndoi:10.1021/acsami.7b14281 311-2\nSperling,C.,Maitz,M.F.,Talkenberger,S.,Gouzy,M.F.,Groth,T.,andWerner,C. Watanabe, J., Marathe, G. K., Neilsen, P. O., Weyrich, A. S., Harrison, K", ". Watanabe, J., Marathe, G. K., Neilsen, P. O., Weyrich, A. S., Harrison, K. A.,\n(2007).Invitrobloodreactivitytohydroxylatedandnon-hydroxylatedpolymer Murphy,R.C.,etal.(2003).Endotoxinsstimulateneutrophiladhesionfollowed\nsurfaces.Biomaterials28,3617–3625.doi:10.1016/j.biomaterials.2007.04.041 bysynthesisandreleaseofplatelet-activatingfactorinmicroparticles.J.Biol.\nSreeramkumar, V., Adrover, J. M., Ballesteros, I., Cuartero, M. I., Rossaint, J., Chem.278,33161–33168.doi:10.1074/jbc.M305321200\nBilbao, I., et al", ". M., Ballesteros, I., Cuartero, M. I., Rossaint, J., Chem.278,33161–33168.doi:10.1074/jbc.M305321200\nBilbao, I., et al. (2014) Neutrophils scan for activated platelets to initiate Westein, E., de Witt, S., Lamers, M., Cosemans, J. M., and Heemskerk,\ninflammation.Science346,1234–1238.doi:10.1126/science.1256478 J. W. (2012). Monitoring in vitro thrombus formation with novel\nStadie,W.C(1920).Amethodforthedeterminationofmethaemoglobininthe microfluidic devices. Platelets 23, 501–509. doi: 10.3109/09537104.2012.7\nblood.J.Biol.Chem.41,237–241", ". Platelets 23, 501–509. doi: 10.3109/09537104.2012.7\nblood.J.Biol.Chem.41,237–241. 09653\nStang,K.,Krajewski,S.,Neumann,B.,Kurz,J.,Post,M.,Stoppelkamp,S.,etal. Wetterö, J., Bengtsson, T., and Tengvall, P. (2000). Complement activation\n(2014).HemocompatibilitytestingaccordingtoISO10993-4:discrimination on immunoglobulin G-coated hydrophobic surfaces enhances the\nbetweenpyrogen-anddevice-inducedhemostaticactivation.Mater.Sci.Eng.C release of oxygen radicals from neutrophils through an actin-dependent\n42,422–428.doi:10.1016/j.msec.2014.05.070 mechanism. J. Biomed. Mater. Res. 51, 742–751", ". J. Biomed. Mater. Res. 51, 742–751. doi: 10.1002/1097-\nStoll,H.,Steinle,H.,Stang,K.,Kunnakattu,S.,Scheideler,L.,Neumann,B.,etal. 4636(20000915)51:4<742::AID-JBM24>3.0.CO;2-D\n(2017).GenerationofLarge-ScaleDNAHydrogelswithexcellentbloodandcell Wijeyeratne, Y. D., and Heptinstall, S. (2011). Anti-platelet therapy:\ncompatibility.Macromol.Biosci.17:1600252.doi:10.1002/mabi.201600252. ADP receptor antagonists. Br. J. Clin. Pharmacol", ". (2011). Anti-platelet therapy:\ncompatibility.Macromol.Biosci.17:1600252.doi:10.1002/mabi.201600252. ADP receptor antagonists. Br. J. Clin. Pharmacol. 72, 647–57.\nStreller,U.,Sperling,C.,Hübner,J.,Hanke,R.,andWerner,C.(2003).Designand doi:10.1111/j.1365-2125.2011.03999.x\nevaluationofnovelbloodincubationsystemsforinvitrohemocompatibility Wu, Y. (2015). Contact pathway of coagulation and inflammation. Thromb", ". (2015). Contact pathway of coagulation and inflammation. Thromb. J.\nassessmentofplanarsolidsurfaces.J.Biomed.Mater.Res.BAppl.Biomater.66, 13:17.doi:10.1186/s12959-015-0048-y\n379–390.doi:10.1002/jbm.b.10016 Xiao,W.,He,J.,Nichol,J.W.,Wang,L.,Hutson,C.B.,Wang,B.,etal.(2011).\nSukavaneshvar,S.(2017).Devicethrombosisandpre-clinicalbloodflowmodels Synthesisandcharacterizationofphotocrosslinkablegelatinandsilkfibroin\nfor assessing antithrombogenic efficacy of drug-device combinations. Adv. interpenetrating polymer network hydrogels. Acta Biomater", ". Adv. interpenetrating polymer network hydrogels. Acta Biomater. 7, 2384–2393.\nDrugDeliv.Rev.112,24–34.doi:10.1016/j.addr.2016.07.009 doi:10.1016/j.actbio.2011.01.016\nFrontiersinBioengineeringandBiotechnology|www.frontiersin.org 10 July2018|Volume6|Article99", "--- Page 11 ---\nWeberetal. HemocompatibilityofBlood-ContactingBiomaterials\nYau,J.W.,Teoh,H.,andVerma,S.(2015).Endothelialcellcontrolofthrombosis. Zimmermann,A.K.,Weber,N.,Aebert,H.,Ziemer,G.,andWendel,H.(2007).\nBMCCardiovasc.Disord.15:130.doi:10.1186/s12872-015-0124-z Effectofbiopassiveandbioactivesurface-coatingsonthehemocompatibilityof\nZhang, J., Zhu, C., Fan, D., Ma, X., Mi, Y., and Xue, W. (2015)", ". (2015). A two-step membraneoxygenators.J.Biomed.Mater.Res.BAppl.Biomater.80,433–439.\nprotocoltoremoveendotoxinsfromhuman-likecollagen.Sep.Sci.Technol.50, doi:10.1002/jbm.b.30614\n993–1001.doi:10.1080/01496395.2014.978467\nZhang, L., Casey, B., Galanakis, D. K., Marmorat, C., Skoog, S., Vorvolakos, Conflict of Interest Statement: The authors declare that the research was\nK.,etal.(2017).Theinfluenceofsurfacechemistryonadsorbedfibrinogen conductedintheabsenceofanycommercialorfinancialrelationshipsthatcould\nconformation, orientation, fiber formation and platelet adhesion", ". Acta beconstruedasapotentialconflictofinterest.\nBiomater.54,164–174.doi:10.1016/j.actbio.2017.03.002\nZhao, Y., Sun, X., Zhang, G., Trewyn, B. G., Slowing, I. I., and Lin, V. Copyright©2018Weber,Steinle,Golombek,Hann,Schlensak,WendelandAvci-\nS. (2011). Interaction of mesoporous silica nanoparticles with human red Adali.Thisisanopen-accessarticledistributedunderthetermsoftheCreative\nblood cell membranes: size and surface effects. ACS Nano 5, 1366–1375", ". ACS Nano 5, 1366–1375. CommonsAttributionLicense(CCBY).Theuse,distributionorreproductionin\ndoi:10.1021/nn103077k otherforumsispermitted,providedtheoriginalauthor(s)andthecopyrightowner(s)\nZhu,S.,Herbig,B.A.,Li,R.,Colace,T.V.,Muthard,R.W.,Neeves,K.B.,etal", ". arecreditedandthattheoriginalpublicationinthisjournaliscited,inaccordance\n(2015).Inmicrofluidico:recreatinginvivohemodynamicsusingminiaturized withacceptedacademicpractice.Nouse,distributionorreproductionispermitted\ndevices.Biorheology52,303–318.doi:10.3233/BIR-15065 whichdoesnotcomplywiththeseterms.\nFrontiersinBioengineeringandBiotechnology|www.frontiersin.org 11 July2018|Volume6|Article99"]